Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 867,864 | 466,790 | 233,769 | 195,555 | 168,979 |
| Cost of Goods | 112,691 | 69,724 | 43,764 | 33,512 | 29,546 |
| Gross Profit | 755,173 | 397,066 | 190,005 | 162,043 | 139,433 |
| Operating Expenses | 914,539 | 316,783 | 311,458 | 214,873 | 210,838 |
| Operating Income | -158,675 | 81,007 | -120,689 | -52,318 | -70,859 |
| Interest Expense | 21,897 | 13,853 | 13,980 | 4,365 | 6,518 |
| Other Income | 13,039 | 6,243 | 189,986 | 14,776 | 11,779 |
| Pre-tax Income | -167,533 | 73,397 | 55,317 | -41,907 | -65,598 |
| Income Tax | -95,530 | 1,300 | 4,135 | 1,199 | 888 |
| Net Income Continuous | -72,003 | 72,097 | 51,182 | -43,106 | -66,486 |
| Net Income | $-72,003 | $72,097 | $52,271 | $-56,776 | $-66,486 |
| EPS Basic Total Ops | -0.05 | 0.05 | 0.04 | -0.04 | -0.05 |
| EPS Basic Continuous Ops | -0.04 | 0.05 | 0.03 | -0.03 | -0.05 |
| EPS Diluted Total Ops | -0.05 | 0.04 | 0.03 | -0.04 | -0.05 |
| EPS Diluted Continuous Ops | -0.04 | 0.04 | 0.03 | -0.03 | -0.05 |
| EBITDA(a) | $-137,816 | $95,435 | $-105,998 | $-40,310 | $-58,236 |